Global hemoglobinopathies market is estimated to reach $7.2billion by 2027, growing at a CAGR of 10.9% till 2027

Global Hemoglobinopathies Market Research Historical Analysis 2016-2020 and Forecast 2021-2028

Hemoglobinopathies are a group of disorders inherited in which there is abnormal production or structure of the hemoglobin molecule. Sickle cell disease (SCD) andthalassemia are blood disorders caused by abnormal hemoglobin that damages and deforms red blood cells.

Market Dynamics

The rising prevalence of hemoglobinopathies is boosting the market growth. For instance, approximately 7% of the worldwide population have hemoglobinopathies and are the most common monogenic diseases.Sickle Cell Disease (SCD)is the most common inherited blood disorder in the United States.According to the Centers for Disease Control and Prevention (CDC), Sickle Cell Disease (SCD) affects approximately 100,000 Americans in 2020. Sickle Cell Disease occurs among 1 out of every 16,300 Hispanic-American births. The prevalence of beta-thalassemia globally is around 288,000, with an incidence of 60,000 births per year.Beta-thalassemia is prevalent in developing countries of Africa, South Asia, Southeast Asia, the Mediterranean region and the Middle East. The total prevalence of beta-thalassemia in the European Union and the United States is estimated to be approximately 19,000 patients. Every year approximately 100,000 children are born with Thalassemia Major around the world, of which 10,000 are born in India.Further, favorable government programs related to hemoglobinopathyare a key driving factor of the market. However, product recallmight hamper the market growth. Moreover, an increasing clinical trial for hemoglobinopathies therapywould provide lucrative opportunities for the market in coming years.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Get sample copy of this report @
https://www.infinitybusinessinsights.com/request_sample.php?id=594796
Top key players @ Bio-Rad Laboratories, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd, PerkinElmer Inc., Sysmex Corporation, Novartis AG, Emmaus Medical, Bristol-Myers Squibb Company, ApoPharma Inc, Gamida Cell, and Acceleron Pharma, Inc.

Based on geography, the global hemoglobinopathies market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America is expected to dominate the hemoglobinopathies market in 2021 due to the rising incident and prevalence of hemoglobinopathies, commercialization of regulatory approval of hemoglobinopathies therapy, and increasing clinical studies on hemoglobinopathies therapy. For instance, Imara Inc., a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat patients suffering from inherited genetic disorders of hemoglobin, has introduced the company’s Forte Phase 2b clinical trials of IMR-687 for patients with beta-thalassemia.IMR-687 is designed to have a multimodal mechanism action on red blood cells, white blood cells, adhesion mediators and other cell types.

TABLE OF CONTENT:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst’s Viewpoints/Conclusions
15 Appendix

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:
Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.
We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

Contact Us:
Amit J
Sales Coordinator
+1-518-300-3575
amit@infinitybusinessinsights.com
https://mobile.twitter.com/IBInsightsLLP
https://facebook.com/Infinity-Business-Insights-352172809160429
https://www.linkedin.com/company/infinity-business-insights/

This release was published on openPR.